Author: Shaun Pruitt, Zacks

Now appears to be an ideal time to get in on the company’s expansion and appealing EPS growth.

After crushing Q4 EPS expectations, these names have favorable momentum.

Soaring 40%-plus this year, it still trades at just 18.6X forward earnings and at a pleasant discount to industry average.

Up over +200% in the last five years, it’s a very viable option to keep in the portfolio for both growth and value.